Bristol-Myers Squibb Company (BMY) - Episode 73 - Sep 29, 2025

Bristol-Myers Squibb ($BMY) is facing a classic "value trap" dilemma: cash flow models scream a fair price near $97 a share, yet the stock trades around $44. We dive into the massive disconnect fueled by deep R&D cuts and a bearish technical trend, which has 73% of Wall Street analysts stuck on the sidelines with a "Hold" rating. But don't look away, bullish options traders are placing heavy bets on a reversal from oversold territory. Tune in to D-Risk as we break down the conflicting signals to reveal the key price level that will determine if this pharma giant is a bargain bin treasure or a falling knife that's about to bounce.